Gapping down
In reaction to earnings/guidance:
- TGTX -41.3%, ZI -20%, ZBRA -15.4%, HLIT -14.7%, RMBS -10.9%, AAN -9.6%, RYI -9.4%, DV -8.6% (also acquiring Scibids), ROK -8.5%, NCLH -7.2%, CRK -7.1%, MPWR -6.5%, PGRE -6.5%, VTS -6.3%, JBLU -6.2%, IQV -5.3%, AMRC -4.7%, KFRC -4.6%, HUN -4.3%, WSO -4.3%, SANM -3.6%, CRC -3.5%, LEG -3.3%, SEAS -3.1% (guidance), WDC -2.5%, IDXX -2.5%, TAP -2.5%, RIG -2.4%, YUMC -2.3%, BMRN -2.2%, RVTY -2.2%, HWM -2.2%, HOLX -2%, DRQ -2% (also acquired Great North Wellhead), LSCC -1.6%, INST -1.5%, RRX -1.4%, BSM -1.3%, BCC -1.2%, GPK -1.2%, ALGM -1.2%, AMKR -1%, PCH -1%, NTB -1%
Other news:
- TARS -5.1% (stock offering)
- QS -3.3% (appoints new President)
- XPEV -3.2% (July deliveries)
- NIO -2.2% (July deliveries)
- ESRT -2% (files mixed shelf)
- RVMD -1% (Revolution Medicines (RVMD) to acquire EQRX in all-stock deal)
Analyst comments:
- SOFI -4.2% (downgraded to Underperform from Mkt Perform at Keefe Bruyette)
- PKX -3.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- SYM -3.6% (downgraded to Mkt Perform from Outperform at William Blair; downgraded to Neutral from Buy at DA Davidson)
- RIVN -2.1% (downgraded to Neutral from Overweight at Cantor Fitzgerald)
- DDL -1.4% (downgraded to Hold from Buy at Daiwa Securities)
- EMN -1.1% (downgraded to Neutral from Overweight at Piper Sandler)
- BRO -0.7% (downgraded to Mkt Perform from Outperform at Keefe Bruyette)